Ahead of Friday's highly anticipated jobs report, investors will watch two key reports out Tuesday for further indications on the domestic economy.» Read More
Matthew Cheslock, Virtu Financial, takes a look at the latest analyst calls, including Susquehanna's downgrade of Red Hat.
Discussing the move in oil and what to expect from the Fed, with CNBC's Bob Pisani, and Ben Willis, Albert Fried & Company.
The FMHR traders reveal their final trades.
Monetary policy in Japan could trump news from the Fed this week, and the kind of inflation the Bank of Japan is creating - with little or no velocity - is a "dangerous game", said Art Cashin, UBS Financial Services director of floor operations.
CNBC's Simon Hobbs reports on all the market moving events in Europe today, as European telecom stocks rise on a report Spain blocked an AT&T bid for Telefonica.
Edward Yardeni, Yardeni Research, and Uri Landesman, Platinum Partners, discuss the Fed's next move ahead of this week's FOMC meeting and its impact on the markets.
CNBC's Jim Cramer has become more cautious on the market right now and conditions are creating a "nightmare scenario" for just about everyone involved, he said on "Squawk on the Street" Monday.
The "Squawk on the Street" news team report on today's top business headlines, including whether the markets are poised to be a big day for bulls, and Smithfield's breakup versus a takeover bid.
Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell.
Phil Orlando, Federated; Neil Irwin, Washington Post, and Jason Trennert, Strategas Research Partners, provide a preview of the Fed's two-day policy-setting meeting this week and its likely outcome.
David Joy, Ameriprise Financial; and Drew Matus, UBS, take a look ahead for signals of what to expect from the Federal Reserve later this week and it's likely impact on interest rates and the markets.
CNBC's Ross Westgate tells you what the markets will be watching as we approach the start of trading in the U.S.
Vasu Menon, VP, Group Wealth Management at OCBC Bank explains why investors shouldn't panic after recent market volatility. He says the opportunity should be seized to invest.
Stephen Thornber, Global Equity Income Fund Manager of Threadneedle Investments explains why emerging market equities still look attractive.
Biotech and drug companies say the benefits of genome research are on the way, and just as importantly, advances are pushing the technology toward affordability.
Mad Money host Jim Cramer shares his final thoughts of the day. What's Bernanke thinking? Cramer offers his take.
Cramer talks about Usana Health, which makes science-based nutritional and personal care products. Stay away, he says. Also, Clovis Oncology, which makes cancer drugs.
Looking back on the best moments from Cramer's live studio audience show last night.
A little speculation could go a long way. Cramer helps you spot opportunities that have staying power. Tonight, he looks at W.R. Grace.
Breaking up is hard to do, but sometimes it pays. Cramer highlights how companies like Covidien can sparkle after spinoffs.